FG appoints Adigwe as NIPRID boss

The Federal Government has appointed Dr Obi Peter Adigwe as the Director General of the National Institute for Pharmaceutical Research and Development (NIPRD). A statement from the agency yesterday said the appointment followed his emergence as the top scorer of a comprehensive interview process which had some of the best candidates of the agency as participants. Prior to his appointment as the Director General of NIPRD, Dr Adigwe was the Executive Secretary of the Pharmaceutical Manufacturers Group (PMGMAN), where he played a key role in the development and implementation of policy initiatives that made considerable impact on the pharmaceutical industry. Some of his achievements in PMGMAN include the prioritisation of the Pharma Industry in the 2016 Fiscal Policy, and the organisation of the 2017 Pharma Expo. He also made significant contributions to the conceptualization of the internationally renowned Medicines’ Security Concept. Dr Adigwe was also the pioneer Head of the Health Policy Research and Development (HPRD) Unit at the Nigerian National Assembly, where he formulated research and development strategies in health policy and also developed innovative and contextual training, research and capacity building modules. He has a significant number of peer reviewed publications including the first knowledge, attitude and practices (K.A.P) study on Ebola in Nigeria, as well as a seminal paper on rational use of medicines. While in the United Kingdom, he also co-authored a write-up that influenced an epoch-making health policy reform in the British Parliament. Dr Adigwe also served on numerous committees and working groups at the highest levels. His appointment takes effect immediately.]]>